In the US, Micafungin (micafungin systemic) is a member of the drug class echinocandins and is used to treat Candida Infections - Systemic, Esophageal Candidiasis and Fungal Infection Prophylaxis.
US matches:
- Micafungin
- Micafungin Intravenous
- Micafungin Sodium
Scheme
Rec.INN
ATC (Anatomical Therapeutic Chemical Classification)
J02AX05
CAS registry number (Chemical Abstracts Service)
0235114-32-6
Chemical Formula
C56-H71-N9-O23-S
Molecular Weight
1270
Therapeutic Category
Antifungal agent
Chemical Name
(4R,5R)-4,5-Dihydroxy-N²-[4-[5-[4-(pentyloxy)phenyl]-3-isoxazolyl]benzoyl]-L-ornithyl-L-threonyl-trans-4-hydroxy-L-prolyl-(4S)-4-hydroxy-4-[4-hydroxy-3-(sulfooxy)phenyl]-L-threonyl-(3R)-3-hydroxy-L-glutaminyl-(3S,4S)-3-hydroxy-4-methyl-L-proline cyclic (6 (WHO)
Foreign Names
- Micafunginum (Latin)
- Micafungin (German)
- Micafungine (French)
- Micafungina (Spanish)
Generic Names
- Micafungin (OS: USAN)
- Micafungin Sodium (OS: USAN)
- FK-463 (IS: Fujisawa)
Brand Names
- Mycamine
Astellas, Spain; Astellas, Greece - Funguard
Astellas, Japan - Mycamine
Astellas, Canada; Astellas, Germany; Astellas, France; Astellas, United Kingdom; Astellas, Indonesia; Astellas, Ireland; Astellas, United States; Astellas Pharma, Sweden
International Drug Name Search
Glossary
| IS | Inofficial Synonym |
| OS | Official Synonym |
| Rec.INN | Recommended International Nonproprietary Name (World Health Organization) |
| USAN | United States Adopted Name |
| WHO | World Health Organization |
Click for further information on drug naming conventions and International Nonproprietary Names.
No comments:
Post a Comment